Novelion Therapeutics Inc. (NVLN) financial statements (2022 and earlier)

Company profile

Business Address C/O NORTON ROSE FULBRIGHT
VANCOUVER, BC V6B 0M3
State of Incorp. BC
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,15455,430108,927141,824155,908118,521307,384
Cash and cash equivalents45,15455,430108,927141,824155,908118,521307,384
Restricted cash and investments 253390    
Receivables28,91222,1919,3393014104,5903,960
Inventory, net of allowances, customer advances and progress billings12,74515,88674,721  
Inventory12,74515,88674,721    
Prepaid expense and other current assets1,442
Assets held-for-sale 300
Income taxes receivable77554
Other undisclosed current assets15,73211,183(27,241)6111,05338,63649,399
Total current assets:102,543104,943166,136142,736157,371161,824363,039
Noncurrent Assets
Inventory, Noncurrent36,20233,94059,003    
Property, plant and equipment1,5852,9204,1594301,0001,8662,655
Long-term investments and receivables   2,0002,000  
Accounts and financing receivable, after allowance for credit loss   2,0002,000  
Intangible assets, net (including goodwill)200,176225,272250,324  
Intangible assets, net (excluding goodwill)200,176225,272250,324    
Other noncurrent assets1,2092,2471,160   
Assets held-for-sale, long lived 300
Other undisclosed noncurrent assets     17735,224
Total noncurrent assets:239,172264,379314,6462,4303,0002,04338,179
TOTAL ASSETS:341,715369,322480,782145,166160,371163,867401,218
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities50,20755,63854,7893,4834,6074,1078,636
Accounts payable6,01213,80017,6091,6561,9432,6096,121
Accrued liabilities44,19541,83837,1801,8271,5281,4982,515
Employee-related liabilities    1,136  
Debt73,677      
Deferred compensation liability    392265 
Estimated litigation liability  64,010    
Deferred revenue and credits     456
Other undisclosed current liabilities286,5048,596  (1,528)(135)1,933
Total current liabilities:410,38864,234118,7993,4833,4714,23711,025
Noncurrent Liabilities
Long-term debt and lease obligation 258,538225,584    
Long-term debt, excluding current maturities 258,538225,584    
Liabilities, other than long-term debt7965966123423881,8461,875
Liability for uncertainty in income taxes  3813423881,8461,875
Other liabilities796596231    
Other undisclosed noncurrent liabilities19,39131,016     
Total noncurrent liabilities:20,187290,150226,1963423881,8461,875
Total liabilities:430,575354,384344,9953,8253,8596,08312,900
Stockholders' equity
Stockholders' equity attributable to parent(88,860)14,938135,787141,341156,512157,784388,318
Common stock552,506551,925551,259475,333467,034466,229471,712
Additional paid in capital79,29573,18569,14997,37797,83895,844296,024
Accumulated other comprehensive income101,640103,802102,587102,969102,969102,969102,969
Accumulated deficit(822,301)(713,974)(587,208)(534,338)(511,329)(507,258)(482,387)
Total stockholders' equity:(88,860)14,938135,787141,341156,512157,784388,318
TOTAL LIABILITIES AND EQUITY:341,715369,322480,782145,166160,371163,867401,218

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues130,432138,43813,574    
Revenue, net138,43813,574    
Cost of revenue(59,697)(77,220)(5,971)  (1,121)(154)
Cost of goods and services sold(59,697)(77,220)(5,971)    
Gross profit:70,73561,2187,603  (1,121)(154)
Operating expenses(120,802)(148,016)(44,309)(25,411)(31,338)(27,369)(54,521)
Other undisclosed operating income   2,06627,509  
Operating loss:(50,067)(86,798)(36,706)(23,345)(3,829)(28,490)(54,675)
Nonoperating income (expense)(1,830)(292)(1,999)358(368)3,2518,511
Foreign currency transaction gain (loss), before tax   32(62)(32)(8)
Other nonoperating income (expense)(1,830)(292)(1,999)4911520760
Interest and debt expense(4,333)      
Other undisclosed loss from continuing operations before equity method investments, income taxes  (13,700)    
Loss from continuing operations before equity method investments, income taxes:(56,230)(87,090)(52,405)(22,987)(4,197)(25,239)(46,164)
Other undisclosed loss from continuing operations before income taxes(50,498)(39,037)     
Loss from continuing operations before income taxes:(106,728)(126,127)(52,405)(22,987)(4,197)(25,239)(46,164)
Income tax expense (benefit)(1,599)(583)(465)(22)192(599)3,900
Loss from continuing operations:(108,327)(126,710)(52,870)(23,009)(4,005)(25,838)(42,264)
Income (loss) from discontinued operations    (66)96787,963
Net income (loss):(108,327)(126,710)(52,870)(23,009)(4,071)(24,871)45,699
Other undisclosed net loss attributable to parent      (1)
Net income (loss) available to common stockholders, diluted:(108,327)(126,710)(52,870)(23,009)(4,071)(24,871)45,698

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(108,327)(126,710)(52,870)(23,009)(4,071)(24,871)45,699
Other comprehensive loss  (382)    
Comprehensive income (loss):(108,327)(126,710)(53,252)(23,009)(4,071)(24,871)45,699
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2,162)1,215    (1)
Comprehensive income (loss), net of tax, attributable to parent:(110,489)(125,495)(53,252)(23,009)(4,071)(24,871)45,698

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: